Onesource Specialty Pharma Q1 FY27: net profit up 13539% to ₹25 crore, revenue up 37%
Onesource Specialty Pharma (BSE: ONESOURCE) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹449 crore (+37.2% year on year), net profit of ₹25 crore (+13539.2%), earnings per share of ₹2.18. The company is valued at about…
What happened
Onesource Specialty Pharma (BSE: ONESOURCE) informed the stock exchanges on 27 October 2026 at 10:06 AM that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹449 crore (+37.2% year on year), net profit of ₹25 crore (+13539.2%), earnings per share of ₹2.18.
From the filing: "Onesource Specialty Pharma Limited has submitted to the Exchange the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026."
Company snapshot
Onesource Specialty Pharma is a small-cap company in the Healthcare sector, with a market value of about ₹17,098 crore.
The stock last traded at ₹1,491.4, against a 52-week range of ₹1,057–₹1,925 (22.5% below the high).
Before this filing the shares had moved −16.0% over the month and −19.3% over three months. Average daily turnover over the last 20 sessions was about ₹31.29 crore.
Promoters held 30.48% at the end of Q1 FY27; 37.23% of promoter shares were pledged. Foreign institutions owned 19.19% and domestic institutions 23.38%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 327 | -0.2 | -0.02 |
| Q2 FY26 | 376 | 10.5 | 0.92 |
| Q3 FY26 | 290 | -88.7 | -7.74 |
| Q4 FY26 | 428 | 4.6 | 0.4 |
| Q1 FY27 | 449 | 25 | 2.18 |
What history shows
BCEIE's records show 1 previous results filing from the company since May 2026.
Across 300 similar disclosures by other Healthcare companies, shares moved +0.9% on average the next day and +1.9% over five days; 54% of them rose the next day.
Market-wide, 9,766 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- OneSource Specialty Pharma Limited Estimates – NSE:ONESOURCE
- Onesource Specialty Pharma - JSW Steel among 5 stocks showing the White Marubozu pattern
- Onesource Specialty Pharma (ONESOURCE.NS) Ticks Higher: Price Holds ₹1,376.2 With Support at ₹1,307.39 - Gap Up Stocks
- OneSource Specialty Pharma Ltd Faces Bearish Momentum Amid Technical Downgrade
- OneSource Specialty Pharma share price jumps 7.4% to ₹1,500 after Q2 profit surges, EBITDA margin expands to over 30%
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.